122 related articles for article (PubMed ID: 12043321)
1. [Contemporary role of scintigraphy in diagnosis, and evaluation of radioiodine therapy for treatment of thyroid diseases].
Jurgilewicz DH; Rogowski F
Wiad Lek; 2002; 55(1-2):88-99. PubMed ID: 12043321
[TBL] [Abstract][Full Text] [Related]
2. [Radioiodine therapy of functional autonomy of the thyroid gland. Treatment results in view of pretreatment scintigraphic diagnosis and early response of triiodothyronine levels to treatment].
Langhammer HR; Laubenbacher C; Hirsch C; Klingele C; Spyra JL; Senekowitsch-Schmidtke R; Schwaiger M
Med Klin (Munich); 1999 Aug; 94(8):415-24. PubMed ID: 10495620
[TBL] [Abstract][Full Text] [Related]
3. Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy.
Meller J; Becker W
Q J Nucl Med; 1999 Sep; 43(3):179-87. PubMed ID: 10568133
[TBL] [Abstract][Full Text] [Related]
4. Value of thyroid carcinoma imaging after therapeutic doses of radioiodine.
Balachandran S; Sayle BA
Clin Nucl Med; 1981 Apr; 6(4):162-7. PubMed ID: 7214771
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphic evaluation of functional thyroidal autonomy.
Meller J; Becker W
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S45-51. PubMed ID: 9867196
[TBL] [Abstract][Full Text] [Related]
6. Thallium-201 scintigraphy of the suppressed thyroid: an alternative for iodine-123 scanning after TSH stimulation.
Corstens F; Huysmans D; Kloppenborg P
J Nucl Med; 1988 Aug; 29(8):1360-3. PubMed ID: 3404253
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism.
Ringel MD; Ladenson PW
J Clin Endocrinol Metab; 1996 May; 81(5):1724-5. PubMed ID: 8626823
[TBL] [Abstract][Full Text] [Related]
9. A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.
Robbins RJ; Larson SM; Sinha N; Shaha A; Divgi C; Pentlow KS; Ghossein R; Tuttle RM
J Nucl Med; 2002 Nov; 43(11):1482-8. PubMed ID: 12411552
[TBL] [Abstract][Full Text] [Related]
10. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.
Ladenson PW; Braverman LE; Mazzaferri EL; Brucker-Davis F; Cooper DS; Garber JR; Wondisford FE; Davies TF; DeGroot LJ; Daniels GH; Ross DS; Weintraub BD
N Engl J Med; 1997 Sep; 337(13):888-96. PubMed ID: 9302303
[TBL] [Abstract][Full Text] [Related]
11. [Radionuclide diagnosis of thyroid diseases].
Slavnov VN
Vrach Delo; 1984 Sep; (9):54-9. PubMed ID: 6209859
[No Abstract] [Full Text] [Related]
12. Nuclear medicine of the thyroid gland. Scintigraphy and radioiodine therapy.
Kintzer PP; Peterson ME
Vet Clin North Am Small Anim Pract; 1994 May; 24(3):587-605. PubMed ID: 8053114
[TBL] [Abstract][Full Text] [Related]
13. Radioisotopes and their use in the diagnosis and management of thyroid disease.
Freeman SJ; Girolamo RF
Clin Geriatr Med; 1995 May; 11(2):189-218. PubMed ID: 7606690
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear medicine diagnosis of the thyroid].
Moser E
Radiologe; 1989 Mar; 29(3):103-8. PubMed ID: 2540508
[TBL] [Abstract][Full Text] [Related]
15. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.
Haugen BR; Pacini F; Reiners C; Schlumberger M; Ladenson PW; Sherman SI; Cooper DS; Graham KE; Braverman LE; Skarulis MC; Davies TF; DeGroot LJ; Mazzaferri EL; Daniels GH; Ross DS; Luster M; Samuels MH; Becker DV; Maxon HR; Cavalieri RR; Spencer CA; McEllin K; Weintraub BD; Ridgway EC
J Clin Endocrinol Metab; 1999 Nov; 84(11):3877-85. PubMed ID: 10566623
[TBL] [Abstract][Full Text] [Related]
16. [Ultrasonic and scintigraphic diagnosis of thyroid diseases].
Zubovskiĭ GA; Sarkisian KIu; Volokhov AB
Med Radiol (Mosk); 1986 Oct; 31(10):45-52. PubMed ID: 3022101
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the relationship between chosen factors and results of whole body scintigraphy with 131I in patients with differentiated thyroid cancers].
Mielcarek W; Dziuk E; Konieczna M; Kowalczyk A; Siekierzyński M
Wiad Lek; 2001; 54 Suppl 1():363-7. PubMed ID: 12182050
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor expression in the thyroid demonstrated with 111In-octreotide scintigraphy.
Becker W; Schrell U; Buchfelder M; Hensen J; Wendler J; Gramatzki M; Wolf F
Nuklearmedizin; 1995 Jun; 34(3):100-3. PubMed ID: 7630741
[TBL] [Abstract][Full Text] [Related]
19. Functional autonomies of thyroid and efficacy of radioiodine therapy.
Kraft O; Stepien A
Cancer Biother Radiopharm; 2007 Apr; 22(2):261-7. PubMed ID: 17600474
[TBL] [Abstract][Full Text] [Related]
20. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
